In vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies

OBJECTIVE(S): Emergence of resistant tumor cells to the current therapeutics is the main hindrance in cancer treatment. Combination therapy, which mixes two or more drugs, is a way to overcome resistant problems of cancer cells to current treatments. Nanobodies are promising tools in cancer therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohseni, Nastaran, Roshan, Reyhaneh, Naderi, Shamsi, Behdani, Mahdi, Kazemi-Lomedasht, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585540/
https://www.ncbi.nlm.nih.gov/pubmed/33149867
http://dx.doi.org/10.22038/ijbms.2020.47782.11000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585540/
https://www.ncbi.nlm.nih.gov/pubmed/33149867
http://dx.doi.org/10.22038/ijbms.2020.47782.11000

Ejemplares similares